Trial Profile
Impact of liver metastasis in patients with metastatic lung adenocarcinoma treated with the first-line gefitinib
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
- 01 Feb 2016 New trial record